Helixgate https://validator.w3.org/feed/docs/rss2.html Rare Diseases at FDA Ongoing | Cancer Accelerated Approvals Moderna and Merck’s mRNA success fuels focus on ‘scaling out and scaling down’ 4 CDMOs to consider when outsourcing manufacturing Can Benelux turn scientific strength into larger biotech scale? BrainChild Bio targets deadly pediatric brain cancer with $116M series A Novartis’ cholesterol-lowering medicine fails Phase 3, clouding Lp(a) horizons Moonwalk pulls in $70M to take fat-targeting RNAi obesity candidate to clinic Drugs@FDA Data Files Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates Novartis hit as Lp(a) drug fails cardio outcomes trial UK’s Claret Capital raises €575m for European biotechs Pharma body sees ‘green shoots’ in UK investment Novartis’ centerpiece of $12B Avidity buyout flunks ‘crucial’ phase 3 test Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped AbbVie-backed ADARx plans IPO to bankroll array of clinical-stage siRNA therapies FDA Grants Accelerated Approval to Etcamah (camizestrant) in Combination with a CDK4/6 Inhibitor for the Treatment of Advanced HR-Positive Breast Cancer Gut Microbiota Metabolites Show Promise Against Disc Degeneration AI model detects lymphovascular invasion in breast cancer MRI scans M2-like microglia drive oligodendrocyte repair in vascular dementia DHCR24 controls endothelial cell aging via the SPHK2/SPNS2-S1P pathway Reeling from past failures, Parkinson’s pipeline enters ‘era of diversification’ AI will only revolutionize drug discovery and development if we play to its strengths When every treatment counts: How clinical trials are changing the outlook for non-Hodgkin lymphoma patients Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment Rare Disease Drug Approvals Mapping the Dynamic Plant Interactome: New Quantitative In Vivo Approaches Emerge Gut microbial metabolites shape Fusobacterium growth and colorectal cancer behavior Turning sorghum stalk lignocellulose into valuable xylooligosaccharides efficiently Gerontology group backs updated immunization guidance Daraxonrasib shows early antitumor activity in RAS-mutant lung cancer Cocoa-shell biochar with ZIF-8 removes loratadine from water FDA Approves Zanvastro (zilganersen) for the Treatment of Alexander Disease Video-based leg agility scoring in Parkinson’s disease links to arm motor impairments Novartis Announces Lp(a)HORIZON Phase III Topline Results for Pelacarsen in Patients with Elevated Lp(a) and Established Cardiovascular Disease (CVD) Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome Metabolomics reveals how tubuloside A inhibits Streptococcus suis biofilms Garlic compound blocks key signal, triggering gastric cancer cell death New machine learning model predicts IVIG resistance in Kawasaki disease Novel kynureninase inhibitor KS79356 slows triple-negative breast cancer progression Emotional Changes in Chronically Ill Patients After a Complementary Therapy Support Program Machine learning and free energy methods discover new tuberculosis KasA inhibitors Multiomics reveals SYNPO2/VNN1 target and microbiota vaccine for atherosclerosis Staff perspectives shape cross-sector care for dual diagnosis patients TScan axes 75% of workforce, prioritizes solid tumor program Treating osteoporosis in older men: review of drug and lifestyle trials Engineered GITR antibody boosts CD4 T cell-dendritic cell teamwork against tumors MCC protein links Wnt signaling to blood vessel polarity and remodeling Enhanced INFO algorithm enables multi-threshold segmentation of colorectal cancer histopathology images Home